## MAR: Marriott International - XLY: Consumer Cyclical

### Executive Summary

VALUE thesis: PEG 1.37 indicates fundamental undervaluation. Consistent execution (4/4 quarters beat estimates). Caution: momentum weakening (-2.8% MRS), overbought RSI (71).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($290.50)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. NoMad Las Vegas now Reserve at Park MGM**
- Source: HOTELSMag.com | 20251201T172150 | Somewhat-Bullish | Relevance: 81%
- MGM Resorts International announced that NoMad Las Vegas will transition to The Reserve at Park MGM on December 17, operating with 293 rooms and suites. This rebranding includes renaming several venues like NoMad Pool to The Terrace Pool and NoMad Bar to The Reserve Bar. The Reserve at Park MGM is also expected to join Marriott Bonvoy’s Autograph Collection in early 2026 as part of MGM Resorts’ strategic partnership with Marriott International.

**2. NoMad Las Vegas Set To Rebrand Into The Reserve at Park MGM**
- Source: Hotel Online | 20251201T150924 | Somewhat-Bullish | Relevance: 75%
-  MGM Resorts International announced that NoMad Las Vegas will rebrand as The Reserve at Park MGM, effective December 17. The transition will also see several NoMad venues renamed, and in early 2026, The Reserve at Park MGM is expected to join Marriott Bonvoy's Autograph Collection, allowing Marriott Bonvoy members to earn and redeem points. This addition will bring the MGM Collection with Marriott Bonvoy to 13 destinations on the Las Vegas Strip.

**3. NoMad Las Vegas to Rebrand as The Reserve at Park MGM in December**
- Source: Hotel News Resource | 20251201T190654 | Somewhat-Bullish | Relevance: 74%
- MGM Resorts International will rebrand NoMad Las Vegas as The Reserve at Park MGM, with the transition expected to be completed by December 17. The rebranded property, featuring 293 rooms and suites, will join Marriott Bonvoy's Autograph Collection in early 2026 as part of MGM Resorts' partnership with Marriott International. This move will expand the MGM Collection with Marriott Bonvoy on the Las Vegas Strip and allow Marriott Bonvoy members to book stays and earn/redeem points.

**4. MGM Resorts (NYSE: MGM) to turn NoMad Las Vegas into The Reserve, eyed for Autograph Collection in 2026**
- Source: Stock Titan | 20251201T093000 | Somewhat-Bullish | Relevance: 74%
- MGM Resorts announced that NoMad Las Vegas will transition to The Reserve at Park MGM, effective December 17, 2025, retaining 293 rooms and suites and refreshing several venue names. The Reserve is anticipated to join Marriott Bonvoy's Autograph Collection in early 2026, expanding booking options and loyalty program benefits through MGM Resorts' partnership with Marriott. This rebrand aims to enhance distribution and loyalty access for the property.

**5. NoMad Las Vegas set to rebrand as Marriott property ahead of new year**
- Source: FOX5 Vegas | 20251201T183500 | Somewhat-Bullish | Relevance: 73%
- NoMad Las Vegas is set to rebrand as "The Reserve at MGM" on December 17, becoming a Marriott Bonvoy Autograph Collection property. This move is part of an ongoing partnership between MGM and Marriott, allowing Bonvoy members to earn points and book stays. The rebrand will include renaming amenities like the pool, library, and bar.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-04 | Truist Securiti | $283 | $278 | +2% |
| 2025-11-18 | Wells Fargo | $329 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-04 | Truist Securiti | main | Hold |
| 2025-11-18 | Wells Fargo | init | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 5 ($0.45M) |
| Sells | 12 ($25.61M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 35.0% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 7.7% (+1.1%)
- Blackrock Inc.: 5.7% (+0.3%)
- JPMORGAN CHASE & CO: 5.0% (+40.6%)
- State Street Corpora: 3.5% (-0.3%)
- Wellington Managemen: 3.4% (+21.7%)

### Key Risks

1. Heavy insider selling: $26M sold (12 transactions in 90 days).
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.37 suggests fair value with growth premium. Forward P/E 26.6x stretched relative to 13% growth. Quality metrics strong (margin 38%). Insider selling cluster ($25.6M in 90 days), potential headwind. Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $77.9B |
| Beta | 1.16 |
| 52W Range | $205.40 - $309.43 |
| Short Interest | 4.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.37 |
| Forward P/E | 26.6 |
| Current P/E | 30.0 |
| YoY Growth | 12.6% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 6.7% to 3.9% (-2.8% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 0.1pp (needs >4.0% for momentum thesis). MRS_5 (-0.3%) diverging from MRS_20 - short-term weakness emerging. AM_20 at 5.0% shows strong absolute momentum above own 20MA. Outperforming sector by 3.5pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (1.51), confirming momentum. RSI overbought at 71, risk of mean reversion.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 3.91% (CS: 84) | Neutral |
| RSI_14 | 70.9 | Overbought |
| MACD Histogram | 1.51 | Bullish |
| vs SMA20 | 1.050x | Above |
| vs SMA50 | 1.105x | Above |
| vs SMA200 | 1.152x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $303.44
- **Stop Loss:** $290.50 (4.3% risk)
- **Target:** $329.32 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 77
- **Position Value:** $23,364.88
- **Portfolio %:** 23.36%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

### Earnings

**Next:** 2026-02-10 (Est: $2.61)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $2.39 | $2.47 | +3.5% |
| 2025Q2 | $2.62 | $2.65 | +1.1% |
| 2025Q1 | $2.25 | $2.32 | +3.0% |
| 2024Q4 | $2.38 | $2.45 | +2.7% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*